Neurology & Neurosurgery Research
ORCHESTRA Early-Stage Parkinson’s Disease Study
This study is currently closed to enrollment.
AGE: 40-75 years old
SEX AT BIRTH: All
HEALTHY PARTICIPANTS: No
SEX AT BIRTH: All
HEALTHY PARTICIPANTS: No
TYPE: Randomized Controlled Clinical Trial
CONDITION: Parkinson’s disease (PD)
CONDITION: Parkinson’s disease (PD)
LOCATION: UH Cleveland Medical Center, UH Suburban Health Center
Study Purpose
The purpose of this research study is to assess an investigational drug, USB0059, to determine if it will slow progression or worsening of early Parkinson’s disease (PD) in people who are not yet on PD medications. There is not yet any medication proven to slow progression of PD, so it is important to discover medications that will do so.
Study ID
- STUDY20220728